|Preferred IUPAC name
3D model (Jmol)
|Molar mass||158.15 g/mol|
|Melting point||126 °C (259 °F; 399 K)|
|Boiling point||Begins to sublime at 100 °C|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
1,4-Naphthoquinone or para-naphthoquinone is an organic compound derived from naphthalene. Several isomeric naphthoquinones are known, notably 1,2-naphthoquinone. 1,4-Naphthoquinone forms volatile yellow triclinic crystals and has a sharp odor similar to benzoquinone. It is almost insoluble in cold water, slightly soluble in petroleum ether, and more soluble in polar organic solvents. In alkaline solutions it produces a reddish-brown color. Vitamin K is a derivative of 1,4-naphthoquinone. It is a planar molecule with one aromatic ring fused to a quinone subunit.
The industrial synthesis involves aerobic oxidation of naphthalene over a vanadium oxide catalyst:
- C10H8 + 3/2 O2 → C10H6O2 + H2O
1,4-Naphthoquinone acts as strong dienophile in Diels-Alder reaction. Its adduct with 1,3-butadiene can be prepared by two methods: 1) long (45 days) exposure of naphthoquinone in neat liquid butadiene taken in huge excess at room temperature in a thick-wall glass tube or 2) fast catalyzed cycloaddition at low temperature in the presence of 1 equivalent of tin(IV) chloride:
1,4-Naphthoquinone is mainly used as a precursor to anthroquinone by reaction with butadiene followed by oxidation. Nitration gives 5-nitro-1,4-naphthalenedione, precursor to an aminoanthroquinone that is used as a dye precursor.
Naphthoquinone forms the central chemical structure of many natural compounds, most notably the K vitamins. 2-Methylnaphthoquinone is a more effective coagulant than vitamin K.
Naphthoquinone derivatives have significant pharmacological properties. They are cytotoxic, they have significant antibacterial, antifungal, antiviral, insecticidal, anti-inflammatory, and antipyretic properties. Plants with naphthoquinone content are widely used in China and the countries of South America, where they are used to treat malignant and parasitic diseases.
Naphthoquinone functions as a ligand (through the electrophilic C=C).
- Merck Index, 11th Edition, 6315.
- Gaultier, J.; Hauw, C. (1965). "Structure de l'α-Naphtoquinone". Acta Crystallographica. 18 (2): 179–183. doi:10.1107/S0365110X65000439.
- Grolig, J.; Wagner, R. (2005), "Naphthoquinones", Ullmann's Encyclopedia of Industrial Chemistry, Weinheim: Wiley-VCH, doi:10.1002/14356007.a17_067
- Braude, E. A.; Fawcett, J. S. (1953). "1,4-Naphthoquinone" (PDF). Org. Synth. 33: 50.; Coll. Vol., 4, p. 698
- M.A. Filatov; S. Baluschev; I.Z. Ilieva; V. Enkelmann; T. Miteva; K. Landfester; S.E. Aleshchenkov; A.V. Cheprakov (2012). "Tetraaryltetraanthra[2,3]porphyrins: Synthesis, Structure, and Optical Properties". J. Org. Chem. 77 (24): 11119–11131. doi:10.1021/jo302135q.
- Babula, P.; Adam, V.; Havel, L.; Kizek, R. (2007). "Naphthoquinones and their Pharmacological Properties". Ceská a Slovenská Farmacie (in Czech). 56 (3): 114–120. PMID 17867522.
- Kündig, E. P.; Lomberget, T.; Bragg, R.; Poulard, C.; Bernardinelli, G. (2004). "Desymmetrization of a meso-Diol Complex Derived from [Cr(CO)3(η6-5,8-Naphthoquinone)]: Use of New Diamine Acylation Catalysts". Chemical Communications. 2004 (13): 1548–1549. doi:10.1039/b404006f.